Skip to main content
OpenTrials
Completed

NCT Number: NCT03921918

Evaluation of Fluid-Filled Expression Core Technology Study - I

A functional model of a fluid-filled, smaller dead volume breast pump has been developed in order to more closely mimic the breastfeeding infant. The technology of fluid-filled pumping has been tested in one prior clinical study and has now progressed to a complete prototype with which the user can assemble, pump, disassemble, clean and reuse.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Medela AG

Baar, 6431, Switzerland

About this study

Current breast pumps function in a way that is different to breastfeeding. These include the seal to the breast, the movement of the nipple, the sensations of warmth and moisture, the variability in frequency, and the strength of the applied vacuum. During breastfeeding the mother's nipple and the infant's mouth form a chamber that is a fluid-filled, no dead volume system, which is needed to create a working vacuum to remove milk from the breast. There is no air visible in the natural system according to ultrasound measurements. This is unlike breast pumps which use an air-filled, large dead volume system, to create a working vacuum. Therefore, a functional model of a fluid-filled, smaller dead volume breast pump has been developed in order to more closely mimic the breastfeeding infant. The technology of fluid-filled pumping has been tested in one prior clinical study and has now progressed to a complete prototype with which the user can assemble, pump, disassemble, clean and reuse.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject ≥ 18 years old
  • Infant is ≥1 and ≤6 month old
  • Subject and baby are healthy according to self-declaration in the "Mother and infant health questionnaire"
  • Subject is predominantly breastfeeding (80% of all feeds, i.e. ≤150 ml formula/day or equal representative amount of solid food)
  • The subject agrees to pump or feed the last time a minimum of 2 hours (hr) before the start of the pumping session at the study site
  • The subject agrees to photographs/3 D scan of the breast and upper body (no face),
  • The subject agrees to a video while pumping
  • The subject signs the informed consent documentation
  • Subject agrees that a maximum of 2 male team members can be present in the room to conduct the usability part of the study
  • The mother accepts that the pumped milk in visit 2 must be donated to the study i.e. cannot be fed to the baby

Exclusion criteria

  • The subject has a nipple size ≥ 21 mm
  • Mastitis (any breast within two weeks prior to enrolment)
  • Engorgement (any breast within two weeks prior to enrolment).
  • Case of current infection as self-declared in the Mother and infant health questionnaire

Treatment and study plan

Breast Pump

Device

Hydraulic Breast pump

Primary outcomes

  1. Recording all Adverse Events

    Time frame: 3 months

    Recording all AE and evaluating the (time of) occurrence, type, seriousness, expectedness, relatedness, and outcome of the adverse events

  2. Observing pump performance

    Time frame: 3 months

    Measuring milk flow volume including time to first ejection.

Secondary outcomes

  1. Measureing user acceptance

    Time frame: 3 months

    Analysing the User Experience Questionnaire as per Laugwitz, Held & Schrepp (2017)

Sponsors and collaborators

Lead sponsor

Medela AG

Industry

Registry information

Acronym: Effect-1

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Apr 19, 2019
Registry last updated
Feb 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.